NO20045233L - Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse - Google Patents

Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse

Info

Publication number
NO20045233L
NO20045233L NO20045233A NO20045233A NO20045233L NO 20045233 L NO20045233 L NO 20045233L NO 20045233 A NO20045233 A NO 20045233A NO 20045233 A NO20045233 A NO 20045233A NO 20045233 L NO20045233 L NO 20045233L
Authority
NO
Norway
Prior art keywords
forms
ondansetron
processes
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20045233A
Other languages
English (en)
Norwegian (no)
Inventor
Judith Aronhime
Szabolcs Salyi
Csaba Szabo
Sandor Molnar
Erzsebet Meszaros Sos
Tivadar Tamas
Original Assignee
Teva Gyogyszergyar Reszvenytar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Reszvenytar filed Critical Teva Gyogyszergyar Reszvenytar
Publication of NO20045233L publication Critical patent/NO20045233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20045233A 2002-04-30 2004-11-29 Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse NO20045233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37639502P 2002-04-30 2002-04-30
PCT/US2003/013220 WO2003093260A1 (en) 2002-04-30 2003-04-29 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them

Publications (1)

Publication Number Publication Date
NO20045233L true NO20045233L (no) 2005-01-28

Family

ID=29401340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045233A NO20045233L (no) 2002-04-30 2004-11-29 Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse

Country Status (15)

Country Link
US (1) US20040019093A1 (pl)
EP (1) EP1465887A1 (pl)
JP (1) JP2005529908A (pl)
KR (1) KR20040104677A (pl)
CN (1) CN1665803A (pl)
AU (1) AU2003223763A1 (pl)
CA (1) CA2483532A1 (pl)
DE (1) DE20320528U1 (pl)
HR (1) HRP20041136A2 (pl)
IL (1) IL164905A0 (pl)
MX (1) MXPA04010845A (pl)
NO (1) NO20045233L (pl)
PL (1) PL373192A1 (pl)
WO (1) WO2003093260A1 (pl)
ZA (1) ZA200408935B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
PT1499623E (pt) * 2002-04-29 2007-08-10 Teva Gyogyszergyar Zartkoeruee ''processo papa a preparação de 1, 2, 3, 9-tetra-hidro-9-metil-3- [(2-metil-1h-imidazol-1-il) metil] -4h-carbazol-4-ona''
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
ES2238001B1 (es) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
WO2005108392A2 (en) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
CN105168186A (zh) 2006-10-02 2015-12-23 Apr应用制药研究股份公司 非粘膜粘着性膜剂型
EP2377526A1 (en) 2010-03-23 2011-10-19 BioAlliance Pharma Fast dissolving drug delivery systems
CN103025321A (zh) 2010-03-23 2013-04-03 生物联合制药公司 快速溶解的药物释放系统
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
WO1993000074A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB2291005B (en) * 1994-07-08 1998-05-20 Milwaukee Electric Tool Corp Bevel angle adjustment mechanism for a compound mitre saw
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
JP3533519B2 (ja) * 2000-03-09 2004-05-31 株式会社アドバンスト・ディスプレイ Ｔｆｔ基板、フィルムキャリアおよび液晶表示素子の製法
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
PT1499623E (pt) * 2002-04-29 2007-08-10 Teva Gyogyszergyar Zartkoeruee ''processo papa a preparação de 1, 2, 3, 9-tetra-hidro-9-metil-3- [(2-metil-1h-imidazol-1-il) metil] -4h-carbazol-4-ona''

Also Published As

Publication number Publication date
JP2005529908A (ja) 2005-10-06
ZA200408935B (en) 2006-07-26
AU2003223763A1 (en) 2003-11-17
DE20320528U1 (de) 2004-09-16
CN1665803A (zh) 2005-09-07
KR20040104677A (ko) 2004-12-10
CA2483532A1 (en) 2003-11-13
MXPA04010845A (es) 2005-01-25
WO2003093260A1 (en) 2003-11-13
PL373192A1 (pl) 2005-08-22
HRP20041136A2 (en) 2005-04-30
US20040019093A1 (en) 2004-01-29
EP1465887A1 (en) 2004-10-13
IL164905A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
NO20074558L (no) Krystallisasjon og rensing av glykopyrroniumbromid
NO20051118L (no) Fremgangsmate til fremstilling av amorfe og keramiske materialer via smeltespinning
NO20045233L (no) Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse
PE20050078A1 (es) Derivados de pirrolidona como inhibidores de maob
MXPA05008705A (es) Derivados de piridina como compuestos fungicidas.
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
NO20055688L (no) Organiske forbindelser
UA89830C2 (ru) Кристаллическая модификация iv пираклостробина, способы ее получения, композиция для защиты растений и применение
FR2940266B1 (fr) Solide cristallise im-20 et son procede de preparation
NO20055454L (no) Smeltedigel til en innretning for a produsere en blokk av krystallinsk materiale og en fremgangsmate for a produsere denne
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
PL1670778T3 (pl) Przegrupowane pentanole, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenia
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
DE50312430D1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
ATE350123T1 (de) Niedrigtemperaturprozess zum extrahieren der hauptkomponenten aus pflanzen
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
NO20064606L (no) Fremgangsmate for a redusere dioksininnholdet av blekejord
ATE297893T1 (de) Verfahren zur herstellung von pyrrolidonen
ATE411310T1 (de) Reinigungsverfahren von moxonidine
NO20092214L (no) Krystallinske former av aryl-substituerte pyrazol-amid forbindelser
MX2008000821A (es) Nuevos derivados de piperidina.
TW200628465A (en) Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
ZA200409615B (en) Method for producing specific crystalline modifications of polymorphous substances.
DK0961770T3 (da) Fremgangsmåder til fremstilling af 3-cyanopyridin ud fra 2-methyl-1,5-pentandiamin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application